Trademark: 90149626
Word
INSIGNIA
Status Date
Tuesday, March 12, 2024
Filing Date
Monday, August 31, 2020
Published for Opposition
Tuesday, January 2, 2024
5 Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
1 Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely, inorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
10 Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposes, namely, for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatus, instruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor
42 Scientific and technological services and research and design relating thereto, in the field of DNA analysis services for scientific research analysis, and scientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services, for scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom, for scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, relating to the results of scientific and medical experiments and tests, relating to the analysis and evaluation of scientific and medical data, and relating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays
The mark consists of the word "INSIGNIA" in stylized form.
Mar 11, 2024
Extension Of Time To Oppose Process - Terminated
Feb 22, 2024
Changes/Corrections After Pub Approval Entered
Feb 20, 2024
Assigned To Petition Staff
Jan 23, 2024
Extension Of Time To Oppose Received
Jan 19, 2024
Teas Post Publication Amendment Received
Jan 2, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 2, 2024
Published For Opposition
Dec 13, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Approved For Pub - Principal Register
Sep 19, 2023
Examiner's Amendment Entered
Sep 19, 2023
Notification Of Examiners Amendment E-Mailed
Sep 19, 2023
Examiners Amendment E-Mailed
Sep 19, 2023
Examiners Amendment -Written
Sep 12, 2023
Previous Allowance Count Withdrawn
Sep 5, 2023
Withdrawn From Pub - Og Review Query
Aug 21, 2023
Approved For Pub - Principal Register
Aug 21, 2023
Examiner's Amendment Entered
Aug 21, 2023
Notification Of Examiners Amendment E-Mailed
Aug 21, 2023
Examiners Amendment E-Mailed
Aug 21, 2023
Examiners Amendment -Written
Aug 19, 2023
Teas/Email Correspondence Entered
Aug 18, 2023
Correspondence Received In Law Office
Aug 18, 2023
Teas Request For Reconsideration Received
May 31, 2023
Notification Of Final Refusal Emailed
May 31, 2023
Final Refusal E-Mailed
May 31, 2023
Final Refusal Written
May 13, 2023
Teas/Email Correspondence Entered
May 12, 2023
Correspondence Received In Law Office
May 12, 2023
Teas Response To Office Action Received
Feb 14, 2023
Notification Of Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action E-Mailed
Feb 14, 2023
Non-Final Action Written
Aug 8, 2022
Teas Change Of Correspondence Received
Aug 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 27, 2022
Report Completed Suspension Check Case Still Suspended
Jul 22, 2022
Suspension Checked - To Attorney For Action
Jan 20, 2022
Report Completed Suspension Check Case Still Suspended
Jul 22, 2021
Notification Of Letter Of Suspension E-Mailed
Jul 22, 2021
Letter Of Suspension E-Mailed
Jul 22, 2021
Suspension Letter Written
Jul 21, 2021
Teas/Email Correspondence Entered
Jul 21, 2021
Correspondence Received In Law Office
Jul 21, 2021
Assigned To Lie
Jul 6, 2021
Teas Voluntary Amendment Received
Jul 5, 2021
Teas Response To Office Action Received
Jan 5, 2021
Notification Of Non-Final Action E-Mailed
Jan 5, 2021
Non-Final Action E-Mailed
Jan 5, 2021
Non-Final Action Written
Jan 4, 2021
Assigned To Examiner
Oct 8, 2020
New Application Office Supplied Data Entered
Sep 3, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
